Occudo Quantitative Strategies LP purchased a new stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 7,428 shares of the business services provider's stock, valued at approximately $662,000.
A number of other institutional investors also recently modified their holdings of EXPO. Barclays PLC increased its position in shares of Exponent by 219.0% during the third quarter. Barclays PLC now owns 96,526 shares of the business services provider's stock valued at $11,127,000 after buying an additional 66,263 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Exponent by 223.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 6,158 shares of the business services provider's stock valued at $541,000 after acquiring an additional 4,254 shares in the last quarter. Argent Capital Management LLC increased its holdings in Exponent by 17.3% during the 4th quarter. Argent Capital Management LLC now owns 28,323 shares of the business services provider's stock worth $2,524,000 after acquiring an additional 4,173 shares during the period. KBC Group NV lifted its stake in Exponent by 62.4% in the 4th quarter. KBC Group NV now owns 2,274 shares of the business services provider's stock worth $203,000 after purchasing an additional 874 shares in the last quarter. Finally, PineStone Asset Management Inc. lifted its stake in Exponent by 12.4% in the 4th quarter. PineStone Asset Management Inc. now owns 98,311 shares of the business services provider's stock worth $8,760,000 after purchasing an additional 10,811 shares in the last quarter. 92.37% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity at Exponent
In related news, VP Richard Reiss sold 1,736 shares of the company's stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the transaction, the vice president now directly owns 1,800 shares in the company, valued at approximately $154,674. The trade was a 49.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.10% of the stock is currently owned by insiders.
Exponent Trading Down 0.5%
Shares of EXPO traded down $0.41 during mid-day trading on Tuesday, reaching $79.55. 28,922 shares of the stock traded hands, compared to its average volume of 244,035. The company has a market cap of $4.04 billion, a price-to-earnings ratio of 37.52 and a beta of 0.95. Exponent, Inc. has a 1 year low of $73.37 and a 1 year high of $115.75. The firm has a fifty day moving average price of $79.22 and a 200 day moving average price of $87.63.
Exponent (NASDAQ:EXPO - Get Free Report) last announced its earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. Exponent had a return on equity of 27.27% and a net margin of 19.52%. The business had revenue of $137.44 million for the quarter, compared to analyst estimates of $134.63 million. During the same period in the prior year, the company earned $0.59 EPS. The company's quarterly revenue was up .2% compared to the same quarter last year. On average, sell-side analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.51%. The ex-dividend date of this dividend is Friday, June 6th. Exponent's dividend payout ratio (DPR) is 58.54%.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
